Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: A pilot study

Pituitary

Volumn 11, Issue 3, 2008, Pages 279-285

  Danilowicz, Karina ^a   Bruno, Oscar Domingo ^a   Manavela, Marcos ^a   Gomez, Reynaldo Manuel ^b   Barkan, Ariel ^c  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b ARGUS Diagnostico Medico   (Argentina)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cortisol replacement; Growth hormone deficiency; Hypopituitarism

Indexed keywords

CHOLESTEROL; CORTICOTROPIN; DESMOPRESSIN; ESTROGEN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; LIPID; PLACEBO; PROGESTERONE; TESTOSTERONE ENANTATE; THYROTROPIN; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADRENAL CORTEX INSUFFICIENCY; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BONE MINERAL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIZZINESS; DRUG DOSE REDUCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FATIGUE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOPHYSECTOMY; HYPOPITUITARISM; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MALE; MORBIDITY; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEAKNESS; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; CUSHING SYNDROME; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 47249148811     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0126-2     Document Type: Article

References (28)

1. Malik IA, Foy P, Wallymahmed M, Wilding JP, MacFarlane IA (2003) Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects. Clin Endocrinol (Oxf) 59:75-81. doi: 10.1046/j.1365-2265.2003.01799.x
2. Attanasio AF, Bates PC, Ho KK et al (2002) Hypoptiuitary control and complications study international advisory board. Human growth hormone replacement in adult hypopituitary patients: Long-term effects on body composition and lipid status-3-year results from the HypoCCS Database. J Clin Endocrinol Metab 87:1600-1606. doi: 10.1210/jc.87.4.1600
3. Besser GM, Jeffcoate WJ (1976) Endocrine and metabolic diseases. Adrenal diseases. BMJ 1:448-451
4. Groves RW, Toms GC, Houghton BJ, Monson JP (1988) Corticosteroid replacement therapy: Twice or thrice daily? J R Soc Med 81:514-516
5. Johannsson G, Rosén T, Bosaeus I, Sjöström L, Bengtsson BA (1996) Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:2865-2873. doi: 10.1210/ jc.81.8.2865
6. Filipsson H, Monson JP, Koltowska-Haggstrom M, Mattsson A, Johannsson GJ (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954-3961. doi: 10.1210/jc.2006-0524
7. Colao A, Di Somma C, Rota F et al (2005) Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. J Clin Endocrinol Metab 90:2056-2062. doi: 10.1210/ jc.2004-2247
8. Esteban NV, Loughlin T, Yergey AZ et al (1991) Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 72:1698-1700
9. McKenna SP, Doward LC, Alonso J et al (1999) The Qol-AGHDA: An instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 4:373-378. doi: 10.1023/A:1008987922774
10. Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288. doi: 10.1016/ 0140-6736(90) 91812-O
11. Beshyah SA, Freemantle C, Thomas E et al (1995) Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 42:179-189. doi: 10.1111/ j.1365-2265.1995.tb01860.x
12. Hoffman AR, Kuntze JE, Baptista J et al (2004) Growth hormone (GH) replacement therapy in adult-onset GH deficiency: Effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2048-2056. doi: 10.1210/jc.2003-030346
13. Mauras N, Pescovitz OH, Allada V, Messig M, Wajnrajch MP, Lippe B, Transition Study Group (2005) Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: A phase III multicenter, double-blind, randomized two-year trial. J Clin Endocrinol Metab 90:3946-3955. doi: 10.1210/jc.2005-0208
14. Christopher M, Hew FL, Oakley M, Rantzau C, Alford F (1998) Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. J Clin Endocrinol Metab 83:1668-1681. doi: 10.1210/jc.83.5.1668
15. Sesmilo G, Biller BM, Llevadot J et al (2000) Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133:111-122
16. Cuneo RC, Judd S, Wallace JD et al (1998) The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 83:107-116. doi: 10.1210/jc.83.1.107
17. Murray RD, Adams JE, Shalet SM (2006) A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. J Clin Endocrinol Metab 91:432-438. doi: 10.1210/ jc.2005-0897
18. Ehrnborg C, Ellegard L, Bosaeus I, Bengtsson BA, Rosen T (2005) Supraphysiological growth hormone: Less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Clin Endocrinol (Oxf) 62:449-457. doi: 10.1111/j.1365-2265.2005.02240.x
19. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76:1505-1510. doi: 10.1210/jc.76.6.1505
20. Hahner S, Loeffler M, Fassnacht M et al (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 92:3912-3922. doi: 10.1210/jc.2007-0685
21. Dunne FP, Elliot P, Gammage MD et al (1995) Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clin Endocrinol (Oxf) 43:623-629. doi: 10.1111/j.1365-2265.1995.tb02928.x
22. Zeiger MA, Fraker DL, Pass HI et al (1993) Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy. Surgery 114:1138-1143
23. Peacey SR, Guo CY, Robinson AM et al (1997) Glucocorticoid replacement therapy: Are patients over treated and does it matter? Clin Endocrinol (Oxf) 46:255-261. doi: 10.1046/j.1365-2265.1997.780907.x
24. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ, HyposCCS Advisory Board U.S. HypoCCS Study Group (2002) Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 87:477-485. doi: 10.1210/jc.87.2.477
25. Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM, West of Scotland Coronary Prevention Study Group (2007) Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med 357:1477-1486. doi: 10.1056/NEJMoa065994
26. Taskinen MR, Nikkilä EA, Pelkonen R, Sane T (1983) Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 57:619-626
27. Krsek M, Silha JV, Jezková J et al (2004) Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome. Clin Endocrinol (Oxf) 60:350-357. doi: 10.1111/ j.1365-2265.2003.01987.x
28. Pirlich M, Biering H, Gerl H et al (2002) Loss of body cell mass in Cushing's syndrome: Effect of treatment. J Clin Endocrinol Metab 87:1078-1084. doi: 10.1210/jc.87.3.1078